Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical TrialJ. Andrew Bird, A. Wesley Burks, Amal Assa’ad et al.|The Journal of Allergy and Clinical Immunology In Practice|2017Cited by 200
A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune–epithelial interfaceJuliette Léon, Christophe Benoıst, Daniel A. Michelson et al.|Proceedings of the National Academy of Sciences|2021Cited by 40